Evidence map›Paper›PMID 40337037›Full record

ArticleIndian journal of surgical oncology2025

Expression of Peroxisome Proliferator-Activated Receptor γ in Human Colorectal Carcinoma and Its Correlation with Clinicopathological Characteristics.

Deepsikha Dharamsaktu, Jyotsna Naresh Bharti, Poonam Elhence, Meenakshi Rao, Jeewan Ram Vishnoi, Subash Chandra Soni, Neeti Rustagi

Abstract read
In one paragraph

Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Deepsikha DharamsaktuDepartment of Pathology, All India Institute of Medical Science, Jodhpur, Rajasthan India.
Jyotsna Naresh BhartiDepartment of Pathology, All India Institute of Medical Sciences, Mangalagiri, Guntur, India.ORCID 0000-0002-5233-8594
Poonam ElhenceDepartment of Pathology, All India Institute of Medical Science, Jodhpur, Rajasthan India.
Meenakshi RaoDepartment of Pathology, All India Institute of Medical Science, Jodhpur, Rajasthan India.
Jeewan Ram VishnoiDepartment of Surgical Oncology, All India Institute of Medical Science, Jodhpur, Rajasthan India.
Subash Chandra SoniDepartment of Surgical Gastroenterology, All India Institute of Medical Science, Jodhpur, Rajasthan India.
Neeti RustagiDepartment of Community Medicine and Family Medicine, All India Institute of Medical Science, Jodhpur, Rajasthan India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxisome proliferator activator receptor γ (PPAR γ) activation may be responsible for inhibiting the growth of cancer cell lines, and drugs that activate PPAR γ may have therapeutic benefits. Therefore, a mutation in peroxisome proliferator activator receptor γ can produce carcinogenesis. This present study aims to assess the expression of PPAR γ by immunohistochemistry in colorectal carcinoma and its correlation with clinicopathological characteristics. Most of the cases were elderly males, and pelvic pain and bleeding were the predominant symptoms. Colon carcinoma was more common than rectal carcinoma. The adenocarcinoma NOS and mucinous carcinoma were the common histological types, and 40% cases showed lymph node metastasis. The PPAR γ expression was present in 61.8% of the patients, and it showed a significant correlation with lymph node metastasis and tumor location (

Indexed as

Colorectal carcinomaLymph node metastasisLymphovascular invasion

Identifiers

PMID40337037
PMCPMC12052650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.